EMA to hold public hearing on quinolone and fluoroquinolone antibiotic safety
The European Medicines Agency (EMA) has announced that its Pharmacovigilance Risk Assessment Committee will hold a public hearing on quinolone and fluoroquinolone antibiotics, as part of an ongoing safety review into the drugs.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | European Medicines Agency (EMA)